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Abstract: Most pathological conditions that cause local or systemic acidosis by overcoming the
buffering activities of body fluids overlap with those diseases that are characterized by glucose
metabolic disorders, including diabetes mellitus, inflammation, and cancer. This simple observation
suggests the existence of a strong relationship between acidosis and insulin metabolism or insulin
receptor signaling. In this review, we summarized the current knowledge on the activity of insulin
on the induction of acidosis and, vice versa, on the effects of changes of extracellular and intracellular
pH on insulin resistance. Insulin influences acidosis by promoting glycolysis. Although with an
unclear mechanism, the lowering of pH, in turn, inhibits insulin sensitivity or activity. In addition
to ketoacidosis that is frequently associated with diabetes, other important and more complex
factors are involved in this delicate feedback mechanism. Among these, in this review we discussed
the acid-mediated inhibiting effects on insulin binding affinity to its receptor, on glycolysis, on
the recycling of glucose transporters, and on insulin secretion via transforming growth factor β
(TGF-β) activity by pancreatic β-cells. Finally, we revised current data available on the mutual
interaction between insulin signaling and the activity of ion/proton transporters and pH sensors,
and on how acidosis may enhance insulin resistance through the Nuclear Factor kappa B (NF-κB)
inflammatory pathway.
Keywords: insulin receptor; acidosis; glucose metabolism; ion/proton transporters; acid-sensing
ion channels
1. Introduction
Acid–base homeostasis and pH regulation are critical for both normal physiology and cell function,
and is subjected to strong regulation. Precise maintenance of pH is needed, both at the extracellular
level and in the cytosol, since changes in the extracellular space immediately impact on the intracellular
cytosolic pH, and the cell machinery is very sensitive to changes in intracellular H+ concentration.
To maintain the acid–base balance, extracellular pH is usually kept around neutral values and within
narrow limits. The most important examples are arterial blood pH that is maintained between
7.36 and 7.44, or the pH of the venous blood that is around 7.6. As an immediate mechanism of
defense against pH changes, several intracellular and extracellular buffers are available at different
body districts. In the blood, the most important is the HCO3−/CO2 buffer system, but hemoglobin or
plasma proteins also substantially contribute to the buffering activity with their numerous histidine
residues. In addition, other proteins with histidine residues at other body districts, or citrate and
hydroxyapatite in bone, have strong alkalinizing activity. Notably, interstitial fluids contain little pH
buffering molecules and, at this level, the pH is likely to be lower and subjected to a more complex
and dynamic gradient. In this case, the pH value varies strongly depending on the type of specific
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tissue, on the individual cell metabolic activity, and on the distance of the specific cell from the nearest
capillary vessel. Due to technical difficulties, this has not been a well-investigated area. However,
next-generation techniques allow for the real time measurement of live-cell metabolism, intracellular
pH, and proton pumping, both through imaging instrumentations and biochemical assays, thereby
opening up the possibility for a better comprehension of the phenomenon for the future.
Different pathological conditions may cause an overcoming of the buffering activities in bodily
fluids. A multitude of potential causes of systemic and local acidosis exists. Local acidification may
result from growth factors or cytokine stimulation of cell metabolism, vascular disease, ischemia,
infection, tumors, or inflammation [1–4]. In fracture healing, immediately after the initial trauma,
fracture hematoma is characterized by hypoxia and low pH [5]. Furthermore, as demonstrated by
Marunaka et al., even in pre-disease stages, pH is drastically lowered in interstitial fluids around
various tissues, including the brain [6]. At a systemic level, in addition to renal and respiratory
diseases, a source of excessive accumulation of H+ are anaerobic exercise, gastroenteritis, the excessive
consumption of proteins or of other acidifying substances, anemias, acquired immunodeficiency
syndrome (AIDS), aging, and menopause, and last but not least, diabetes. Remarkably, most of
the aforementioned situations overlap with those which occur with an altered glucose or insulin
metabolism, suggesting a strong relationship between acidosis and insulin metabolism or insulin
receptor signaling.
Insulin is the most potent physiological anabolic known agent, promoting the storage and
synthesis of lipids, protein, and carbohydrates, and inhibiting their breakdown and release into
the body’s circulation [7]. Insulin is particularly active in muscle and liver cells and is also often
coupled with fatty acid uptake, especially in adipose cells [8]. However, all mammalian cells virtually
possess insulin receptors (IR), and hence respond to insulin. Additional notable insulin target cells
with a metabolic function include macrophages, endothelial cells, and insulin-producing pancreatic
β-cells [9].
In this review, we described how insulin activity modulates pH regulation, and vice versa, how
changes in pH—both at the extracellular or the intracellular compartments—regulate insulin signaling
and glucose metabolism.
2. Insulin-Mediated Increase of Glycolysis and Local Acidosis
One of the major functions of insulin is a stimulatory effect on glycolysis that occurs when
there is a rise in the level of circulating glucose. In turn, glycolysis causes lactic acid production.
Hyperlactatemia is a recurrent clinical feature of diabetic patients [10] and has been directly associated
with acidosis through a cause-and-effect relationship. However, the correlation between the high blood
concentration of lactate and acidosis in diabetes is far from being clear. In a clinical context, lactic
acidosis can occur either due to excessive production of lactate at the tissue level or impaired lactate
metabolism. Notably, hyperlactatemia may also occur with a normal serum pH or with alkalosis due to
the presence of a mixed acid–base disturbance, where a concomitant respiratory or metabolic alkalosis
masks the effect of the elevated lactic acid concentrations.
In more detail, regarding the excessive production of lactate, it is important to note that it has often
been mistakenly thought that acidosis associated with lactic acid production is due to the dissociation
of lactic acid and formation of H+ [11]. Already in 2004, Robergs disproved this conception by showing
that the reaction catalyzed by lactic dehydrogenase (LDH) produces lactate and not lactic acid, and that
production of lactate rather consumes H+ [12]. Based on the same concept, more recently, Corbet et al.
discussed that lactate and H+ ions are separate entities [13]. In particular, under deep hypoxia, lactate
and H+ are produced independently and only limited fractions of each combine to form lactic acid,
as the pKa (~3.9) for the carboxyl hydrogen dissociation remains well below cytosolic pH and even
extracellular pH. Furthermore, when most glucose-derived pyruvate is reduced into lactate, the full
conversion of glucose into two lactate molecules and two H+ ions in hypoxic cancer cells is only
theoretical since some glucose molecules are diverted into other metabolic pathways [13]. However,
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the lactate gradient across the cell membrane influences H+ efflux since lactate is transported across
the cell membrane by monocarboxylic acid transporters (MCT), mainly by the MCT4, through a
symport of H+ across the cell membrane [14]. Finally, once lactate reaches the extracellular space, the
lactate-based acid–base balance is influenced by several interacting variables—not only including
the electrical charge balance and conservation of mass, but also the equilibria among bicarbonate ion
formation, carbonate ion formation, water dissociation, and weak acid dissociation. Thus, in summary,
accumulation of lactate might result in an increase of extracellular acidification even if it strongly
depends on different variables (Figure 1).
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lactate is uptaken mainly by the MCT1 isoform, thereby causing a final alkalinization effect [16]. Thus, 
a reduced lactate metabolism may indirectly cause acidification. 
Finally, it should be considered that lactate exists as two optical isomers in nature: D-lactate and 
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In conclusion, at least at the cell level, insulin binding to IR and the following activation of 
glycolysis might be a direct cause of interstitial acidification. 
  
Figure 1. Insulin stimulation produces extracellular acidification. The insulin stimulated glucose
uptake from the glucose transporters (GLUT) and glycolysis. Accumulation of lactate from glycolysis
leads to a progressive increment of lactate and proton concentration. Protons are then transported
across the cell membrane through several transporters, including monocarboxylate transporters (MCT),
that also transport lactate to the extracellular space (orange arrow, the route of insulin; green allows,
the route of the products of glycolysis, lactate and protons; blue arrow, the route of protons).
In addition, several proton transporters other than MCT can be used to promptly carry protons
outside the cell. For more details, see different reviews available in this specific field [4,15].
Regarding the impaired lactate metabolism and its role in hyperlactatemia-induced acidosis,
lactate can by uptaken to be metabolized by various cells and tissues, such as liver, germ cells, and
neurons, converting to pyruvate via LDH and subsequently serving as an energy source. In this case,
lactate is uptaken mainly by the MCT1 isoform, thereby causing a final alkalinization effect [16]. Thus,
a reduced lactate metabolism may indirectly cause acidification.
Finally, it should be considered that lactate exists as two optical isomers in nature: D-lactate
and L-lactate [17]. L-lactate is by far the more abundant form in humans and mammals, existing at
concentrations 100 times greater than D-lactate in blood. D-lactate can be metabolized by human cells,
although at a much lower level than L-lactate since it is mainly metabolized by the bacteria of the gut
microbiota. To date, it is not very clear whether the hyperlactatemia in diabetic patients is due to the
increased concentration of L-lactate and D-lactate, and whether lactate acidosis is mainly due to the
high concentration of D-lactate in the blood, rather than to L-lactate [18,19].
Going back to the association between glycolysis and acidosis, based on Warburg’s findings [20],
direct evidence of a correlation between glycolysis and extracellular acidosis in cancer has been
produced by combining magnetic resonance imaging, through coupling 18F-fluoro-2-deoxy-D-glucose
([18F]FDG) positron emission tomography (PET) and acido chemical exchange saturation transfer
magnetic resonance imaging (acidoCEST MRI) [21,22]. These studies have demonstrated a significant
inverse correlation between extracellular tumor pH and [18F]FDG uptake.
In conclusion, at least at the cell level, insulin binding to IR and the following activation of
glycolysis might be a direct cause of interstitial acidification.
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3. Acidosis-Mediated Effects on Insulin Activity and Resistance
3.1. Effects of Acidosis on Insulin Sensitivity and Release
pH is known to modify insulin activity, and that acidification is considered as a mechanism of
insulin resistance. By using in vivo models, it was demonstrated that pH regulation modifies basal and
glucose-stimulated insulin secretion since hyperglycemia induced by the glucose load decreases more
rapidly in alkalotic than in normal rats [23,24]. Previously, metabolic ketoacidosis was considered as
the main cause. This was due to the fact that, both in human diabetic patients with metabolic acidosis
and in animal models of diabetes, insulin resistance and the lack of the induction of glucose uptake
and glycolysis were accompanied by increased concentrations of ketone bodies in the blood flow [25],
and because animal models of severe ketoacidosis develop insulin resistance [26]. In the late nineties,
studies on human patients on hemodialysis showing insulin resistance demonstrated that alkalinizing
treatment with oral sodium bicarbonate (NaHCO3) significantly increased insulin sensitivity and
secretion [27]. Finally, by using the euglycemic clamp technique, Reaich et al. further confirmed
that NaHCO3 treatment of patients with metabolic acidosis from chronic renal failure significantly
increased insulin sensitivity [28].
The cause-and-effect relationship between changes in pH environments and alterations in insulin
activity is still piecing. This is possibly due to the several variables that make the picture increasingly
more complex. One possible cause of acidosis-induced insulin resistance has been demonstrated in
transformed cells. Exposure to low pH directly reduces glycolysis, both after acute [29,30] or chronic
exposure [31]. In the latter case, glycolysis reduction is obtained through a switch to glutamine
metabolism and is mediated by a nicotinammide adenina dinucleotide (NAD)(+)-dependent increase
in sirtuin 1 (SIRT-1) deacetylase activity that deacetylates hypoxia-inducible factor (HIF) proteins to
adapt to the acidic environment [31] (Figure 2a).
In addition, as demonstrated in human breast cancer Bcap37 cells, an acid pH may decrease
glucose uptake and the glycolytic flux by directly inhibiting the activities of most glycolytic enzymes,
including hexokinase (HK), aldolase, pyruvate kinase (PK), and LDH, with particular reference to
phosphoglucose isomerase (PGI), phosphofructokinase (PFK), triosephosphate isomerase (TPI), and
enolase, and through a mechanism that is independent of the presence of lactic acid [32]. Furthermore,
incubation with an acid medium may down-regulate glycolysis also in normal cells. As an example, in
mesenchymal stromal cells (MSC), exposure to an acid medium (6.6–6.7) changes the cellular metabolic
profile since the expression of glucose transporters is significantly reduced and the ratio between
MCT1 and MCT4 is up-regulated [33]. MCT1 mediates lactate uptake. Conversely, MCT4 facilitates
the release of lactate into the extracellular environment, and both MCT1 and MCT4 are expressed both
from normal and cancer cells [15,34,35]. In acid-loaded MSC, high levels of MCT1 increase lactate
upload, whereas inhibition of GLUT1 and GLUT3 reduces glucose uptake, implying that under this
stress condition MSC switch from glycolysis to OxPhos. This metabolic switch is also confirmed
by a reduced expression of lactate dehydrogenase A (LDH-A) and pyruvate kinase isozymes m2
(PKM2) [33]. According to these data, it is possible to speculate that, at the individual cell level,
cytosolic pH controls the glycolytic rate through a feedback mechanism because of the need to reduce
the production of protons from glycolysis and thereby indirectly causing insulin resistance.
Finally, at a systemic level, it is known that acidification of the extracellular fluids stimulates the
release of TGF-β in normal cells, since either in MSC, in proximal tubular cells, or in hippocampal
cultures, in comparison to normal conditions, acidosis causes a fourfold increase of the level of
expression of TGF-β or of TGF-β1 bioactivity [33,36,37] (Figure 2b). In turn, the systemic release of
TGF-β modulates pancreatic development and islet homeostasis and function as TGF-β inhibits the
replication of β-cells [38–40]. These data indirectly suggest that the acid-induced systemic release of
TGF-β might decrease the circulating level of insulin, thereby partially contributing to the feedback
inhibitory mechanism of acidosis that ultimately results in insulin resistance.
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Figure 2. Effects of acidosis on insulin sensitivity and release. Low extracellular pH may interfere with
insulin sensitivity and release in different ways. (a) Acidosis switches the cellular metabolism from
glycolysis to other metabolic pathways, like glutamine metabolism via the Sirtuin 1 (SIRT-1) deacetylase
activity that deacetylates hypoxia-inducible factor (HIF) proteins, or via the inhibition of the expression
of glycolytic enzymes or through the increase of monocarboxylate transporter MCT1/MCT4 pathway;
(b) acidosis induces the transcription and the protein expression of TGF-β that, in turn, inhibits insulin
release at the systemic level; (c) acidosis reduces at least 40% the binding affinity between insulin and
IR; (d) acidosis interferes with the recycling process of both IR and insulin, by modifying the lysosome
intraluminal pH and the number of lysosomes (blue arrow, the route of protons, black arrows, the
route of insulin/IR complexes; T-bar, inhibition).
3.2. Effects of Acidosis on Insulin Receptor Expression, Activation, and Signaling
Acid-induced insulin resistance has been observed in several cell types [25,41–43]. A possible very
simple reason for this effect is reduced insulin binding to its receptor at high proton concentrations
(Figure 2c). Igarashi et al. have elegantly shown that in adipocytes, lowering of extracellular pH
is associated with a reduced insulin binding rate (up to 70%) [25]. In this experimental set, the
authors demonstrated that such an effect was mainly due to a reduction in insulin binding affinity
to its binding sites, without affecting the number of IR per cell. A reduced insulin binding rate
at low pH, compared to neutral pH, has also been demonstrated in fibroblasts, erythrocytes, and
myoblasts [41–46]. In particular, in L6 myoblasts, the insulin binding to IR was down-regulated
up to 50% at pH 6.8 [42]. Acidosis thus has the potential to directly affect the insulin-stimulated
glucose uptake by interfering with the first step of the insulin signaling pathway, the IR activation,
which, as a consequence, might impair the downstream IR signaling. Insulin stimulates glucose
uptake mainly in a phosphatidylinositol 3-kinase (PI3K)-dependent pathway. After binding to IR,
the autophosphorylation of IR and of the second messenger insulin receptor substrate-1 (IRS-1) leads
to the activation of PI3K and the downstream Akt-mediated signaling. As a confirmation of this
hypothesis, in rat myoblasts, a low pH (6.8) significantly affected the 100 nM insulin stimulation of
Tyr1146, Ser473, and Thr308 phosphorylation of IR. On the contrary, the expression of IR was not
affected [42]. By using radiolabeled insulin, the same authors also demonstrated that the reduced
IR phosphorylation was due to decreased insulin binding affinity to the receptor that was inversely
correlated to the level of pH [42]. Notably, extracellular acidosis might also directly interfere with
MEK/ERK (mitogen-activated protein kinases/extracellular signal-regulated kinases) signaling and
Akt activation, regardless of insulin stimulation [4].
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Finally, the level of expression of IR at the plasma membrane is strongly dependent on receptor
recycling and lysosomal activity. Receptor-mediated endocytosis is an essential mechanism for several
important physiological processes, and similarly to other receptor tyrosine kinases, IR undergoes
ligand-induced internalization. After internalization, IR can be recycled to the cell surface, or can also
undergo lysosomal degradation [9]. This event requires a specific amino-acid motif located at the
intracellular part of the IR juxtamembrane domain. This motif targets the receptor to clathrin-coated
pits, and from there to lysosomes, where the level of acid pH is thought to enhance insulin release [47].
In many cell types, insulin itself stimulates receptor endocytosis and accelerates the rate of receptor
degradation. This process, called down-regulation, results in a decrease in the number of cell surface
receptors and may be important to reduce signals initiated by insulin binding [48]. Whether this
is a mechanism of insulin resistance is still controversial. However, it is proven than continuous
exposure to high insulin levels induces subtle derangements of intracellular receptor trafficking and
insulin degradation, and these alterations may contribute to insulin resistance of hyperinsulinemic
states, such as obesity and Type 2 diabetes [49]. The lysosomal activity that regulates the internal
trafficking of IR, as well as of insulin, might be affected by a reduced extracellular pH value. As an
example, in breast cancer cells, rhabdomyosarcoma cells, and osteosarcoma cells, incubation with an
acid medium increased the lysosomal diameter and decreased the luminal pH [50–52]. Thus, changes
in the extracellular pH that are accompanied by changes in the intracellular pH and in lysosomal pH
might be a critical factor for insulin secretion and insulin resistance (Figure 2d).
3.3. Effect of Acidosis on the Expression of GLUT Transporters
Insulin increases energy storage or utilization mainly through the regulation of the uptake of
glucose by inducing the expression on the cell membrane of the GLUT4 transporter [53]. In patients
with type 2 diabetes, the expression levels of GLUT4 in skeletal muscles are significantly decreased,
resulting in a decreased glucose-processing ability. More rarely, GLUT1 has also been associated
with insulin-mediated glycolysis regulation [54]. In more detail, insulin-induced glucose uptake is
heavily regulated by the translocation of GLUT transporters to the cell membrane and the lasting
of GLUT4 expression at this site. As for the IR, GLUT4 is continuously recycled and relocated
between the plasma membrane and the intracellular compartment [53]. GLUT4 recycling is the
result of consecutive and tightly regulated steps, including endocytosis, sorting into specialized
vesicles, exocytosis, tethering, and fusion of the protein. In the absence of insulin, GLUT4 slowly
recycles between the plasma membrane and vesicular compartments within the cell, where most of
GLUT4 resides. Conversely, insulin stimulates the translocation of a pool of GLUT4 to the plasma
membrane through a process of target endocytosis, where GLUT4 endocytosis is simultaneously
attenuated [7]. The whole phenomenon involves signal transduction from the IR, vesicle trafficking
(sorting and fusion processes), and actin cytoskeleton modifications, which are all supposed to require
small guanosintrifosfato hydrolases (GTPases). In particular, various members of the Ras, Rad,
Rho, Arf, and Rab families regulate the traffic of the GLUT4-containing vesicles [55], like Rab4b in
adipocytes [56]. Also, Rab11 has been associated with GLUT4-containing vesicles’ redistribution in
response to insulin [57,58]. As discussed for IR, changes of extracellular pH might regulate the activity
of endosomal vesicles, thereby determining the extent of GLUT4 re-localization and recycling. Actually,
in HSG cells, extracellular acidosis up-regulated Rab11b expression and protein abundance and caused,
as an example, the translocation of the vacuolar proton pump V-ATPase from intracellular pools
toward the plasma membrane [59]. To date, it is not known how lowering the pH modulates small
GTPases expression and their activity in determining GLUT recycling. It is demonstrated, however, at
least in MSC, that the incubation with an acid medium promotes the down-regulation of the expression
of GLUT1 and GLUT3 [33]. However, this hypothesis deserves further investigation.
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4. Intracellular pH Regulation by Proton/Ion Transporters and Insulin Secretion
To avoid the death-inducing stimulus of a high intracellular accumulation of protons that can
be derived both from a reduction of extracellular pH or an increase of glycolysis, cells express
different proton flux regulators at different extents, depending on the tissue of origin [15]. These
pump/transport extrude protons out of the cytosol to maintain the cytosolic pH. Among these,
V-ATPase is widely expressed at the lysosomal membrane, whereas Na+/H+ exchangers (NHE), MCT,
and carbonic anhydrases (CA) are expressed at the cytoplasmic membrane [60–62]. The activity of
these transporters/pumps have the net effect to reduce the luminal lysosomal pH and the pH of
the extracellular space [4,15]. As these transporters are activated, intracellular pH (pHi) rises, albeit
temporarily. However, chronic exposure to an excess of protons produces a paradoxical gradual and
sustained increase of pHi. One of the most common examples for the constant rise of pHi in concert
with chronic extracellular acidosis is cancer [63].
The rise of pHi is widely known as a critical factor for insulin secretion. One of the most
studied models in this context are pancreatic β-cells. Glucose load in these cells, at concentrations
above 3–5 mM, induces cellular depolarization and pHi transitory increments (up to 6.4–6.8 values)
that directly stimulates insulin secretion [64–66]. Furthermore, Nabe et al. have demonstrated that
diphenylhydantoin, a drug used for the treatment of epileptic patients, inhibits glucose-induced insulin
release from pancreatic islets by decreasing intracellular proton concentration [67].
Although such a mechanism has not been fully elucidated, the increase of pHi after glucose
loading in β-cells seems to be based on the presence of extracellular Na+ and on the activity of
sodium–hydrogen exchangers (NHE), since it is inhibited by 5-(N-ethyl-N-isopropyl) amiloride,
an NHE inhibitor [65,66]. According to these data, it is reasonable to speculate that the rise of
pHi after glucose uptake is due to the activity of the NHE Na+/H+ antiporter that counteracts the
glycolysis-induced intracellular acidification (Figure 3A).
A similar phenomenon has also been observed in muscle cells. At 37 ◦C, acute exposure to
insulin (10−7 M) and the resulting increase in glucose uptake produced an increase of pHi of 0.11 units
in 10 min. This increase became apparent 2 min after the addition of the hormone, and maximal
elevation of pHi was observed after 10 min, remaining elevated for up to 60 min [68]. In this case, pHi
alkalinization was also prevented by amiloride. However, a recent review that summarized the most
recent results on NHE and insulin clarified that plasmalemmal full-length NHE1 defends β-cells from
intracellular acidification, but has no role in stimulus-secretion coupling and is not causally involved in
glucose-induced alkalinization of the β-cell [69]. The discrepancy of the data reported in the literature
so far on the relationship between the alkalinization activity of NHE and the stimulatory effect of a
pHi rise on insulin secretion suggests the need to better clarify the phenomenon.
NHE also contributes to pHi regulation in arterial endothelial and smooth muscle cells and might
thereby strongly influence blood pressure. In this respect, it is interesting to note that hypertensive
patients often develop insulin resistance and hyperinsulinemia [70]. This is a chronic condition
that may cause a paradoxical opposite effect in respect to those represented in Figure 3A. By using
human red blood cells from patients with essential hypertension compared to red blood cells from
normotensive subjects, it appeared that hypertensive patients had elevated basal NHE activity but a
blunted response to insulin [71]. In this setting, a negative feedback mechanism might be suggested to
prevent supplementary uptake of glucose that, after chronic exposure to insulin, would excessively
acidify the cytosol (Figure 3B).
As for NHE, CA activity and its regulation of pHi might be involved in the altered metabolism
of chronic hypertensive patients. CA is a well-characterized, pH regulatory, zinc-containing
enzyme in most of the tissues in the body that catalyzes the reversible hydration of carbon
dioxide: CO2+ H2O<–>HCO3−+H+. Changes in CA activities have already been associated with
cancer-altered metabolism [15]. By using p-nitrophenyl acetate as a substrate and acetazolamide,
a CA9-specific inhibitor, in erythrocytes from normotensive and essential hypertensive subjects,
Parui et al. demonstrated that two different levels of CA activities could be detected in these patients.
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One group showed much lower CA activity (mean ± SD, 0.88 ± 0.19 U/min/mL), whereas the other
group showed higher CA activity (mean ± SD, 1.77 ± 0.23 U/min/mL) than normotensive controls
(mean ± 1 SD, 1.41 ± 0.1 U/min/mL), and concluded that essential hypertensive patients were
associated with altered CA activity [72]. Although the role of CA activity and other transporters that
might modulate pHi in insulin sensitivity remains largely unexplained, these data altogether pave for
pharmacological manipulations of pHi to treat insulin resistance.Int. J. M l. S i. 2019, 20, x 8 of 15 
 
 
Figure 3. Intracellular pH regulation by NHE transporter, and insulin secretion and sensitivity. (A) A 
rise in intracellular pH (pHi) after glucose uptake is due to the activity of the NHE Na+/H+ antiporter 
that is counteracting the glycolysis-induced intracellular acidification. The increase of pHi then 
directly stimulates insulin release; (B) in chronic hyperglycemia, a negative feedback mechanism may 
prevent supplementary uptake of glucose that, after chronic exposure to insulin, would excessively 
acidify the cytosol. This mechanism might cause a paradoxical effect mediated by a high level of NHE 
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Figure 3. Intracellular pH regulation by NHE transporter, and insulin secretion and sensitivity.
(A) A rise in intracellular pH (pHi) after glucose uptake is due to the activity of the NHE Na+/H+
antiporter that is counteracting the glycolysis-induced intracellular acidification. The increase of pHi
then directly stimulates insulin release; (B) in chronic hyperglycemia, a negative feedback mechanism
may prevent supplementary uptake of glucose that, after chronic exposure to insulin, would excessively
acidify the cytosol. This mechanism might cause a paradoxical effect mediated by a high level of NHE
expression, thereby reducing insulin sensitivity (orange arrow, the route of insulin; blue arrow, the
route of protons; T-bar, inhibition).
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5. Insulin Receptors and Sensing Extracellular Acidosis
Insulin-stimulated glucose uptake and glycolysis are reduced at low extracellular pH, whereas
insulin secretion is enhanced when pHi rises. It is then possible to speculate that specific mechanisms
of sensing pH variation and gradient between the extracellular and the intracellular spaces exist,
accounting for the activation of the insulin pathway and metabolic activity. Several extracellular
proton-sensing mechanisms are expressed on cell membranes in many biological systems. The existence
and the apparent redundancy of multiple pH surveillance systems attest to the concept that acid–base
regulation is vital for cell and tissue homeostasis [73]. Indeed, in addition to carrying the multiple
currents evoked by protons, these acid-sensing ion channels play fundamental roles in cell signaling
and allow the host cell to respond to benign or harmful environmental changes [74,75]. There are
at least two types of proton-sensing mechanisms, which sense variations of the extracellular proton
concentration and transduce their signal inside the cells: acid-sensing ion channels (ASICS) and
transient receptor potential vanilloid (TRPV) ion channels. ASICS and TRPV can detect a broad range
of physiological pH changes, especially during pathological and synaptic cellular activities in neurons.
Emerging evidence indicates that many of the acid-sensitive ion channels and receptors also play a role
in the acid-evoked feedback regulation of homeostatic reactions, and can be expressed from cells other
than neurons. As an example, ASICs have been detected in cells of the mesenchymal lineage [76], and
with particular regard to ASIC3, knockout mice are protected against age-dependent glucose tolerance
with enhanced insulin sensitivity [77]. By using the TRPV inhibitor capsaicin or TRPV knock-out mice,
several types of TRPV have been revealed to contribute to cell function in pancreatic β-cells, including
glucose metabolism and insulin secretion [78].
In addition to ionotropic ion channels, metabotropic proton-sensing G protein-coupled receptors
(GPCR) have been recently identified as a proton-sensing machinery. While ionotropic ion channels
usually sense strong acidic pH, proton-sensing GPCRs sense a pH of 7.6 to 6.0 and mediate a variety of
biological actions under neutral and mildly acidic pH environments [79]. Referring to ovarian cancer,
in addition to ASIC3, the proton-sensing GPCR G protein-coupled receptor 1 (OGR1) has been proven
to function in physiological events, such as insulin secretion and/or normal glucose metabolism.
OGR1 is activated by neutral or mildly acidic pH (pH 7.4~7.0) and stimulates the processes of the
KATP channel and/or VDCC, and thereby enhances glucose-stimulated insulin secretion through the
phospholipase C (PLC)/Ca2+ signaling pathways [79]. Finally, in normal pancreatic β-cells, OGR1
agonists (small molecule 3,5-disubstituted isoxazoles) stimulate insulin synthesis [79].
In conclusion, current fragmentary data suggest that a fine-tuning of insulin activity and
sensitivity is under the control of pH surveillance systems, a concept that might strongly impact
on our understanding of the regulation of glucose homeostasis. However, the role of proton-sensing
receptors in insulin sensitivity and release is still unclear and deserves further investigation.
6. Insulin Receptor-Induced Inflammatory Pathway and Acidosis
Tissue acidification (pH decrease of at least 0.5–1.0 pH unit) is commonly associated with
inflammation [80]. Indeed, after sensing the extracellular pH changes, ASICs might initiate an
inflammatory response [75]. As an example, lowering pH promotes the expression of the mRNA
messenger of IL-6, and IL-8, as well as of NF-κB1, RelA, and RelB already after 3 h from the exposure
to acidosis (pH 6.8), and after 24 h, it promotes the intranuclear protein expression of members of
the NF-κB family and the release of the inflammatory cytokines IL-6 and IL-8, both in human MSC
and osteoblasts [76,81]. Similarly, GPCRs that can sense the acid stimulus can mediate inflammatory
and related responses, like for T-cell death-associated gene 8 (TDAG8, also known as GPR65), that
enhances the production of IL-6, TNF-α, and IL-1β in the infarcted hearts of mouse models [82].
Activation of inflammatory pathways by acidosis can, in turn, impair glucose metabolism
and cause systemic insulin resistance. Lipid-induced insulin resistance has been associated with
inflammation in epidemiological studies, and by means of different models, several authors have
demonstrated that induction of NF-κB activation reduces net insulin-stimulated glucose uptake.
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For an extensive review, see Reference [83]. In particular, Chang et al. have shown that in C2C12
myotubes, transfection with siRNA against the NF-κB member, the nuclear factor of kappa light
polypeptide gene enhancer in B-cells inhibitor alpha insulin receptor substrate 1 (IκBα), for 24 h leads
to a twofold induction of NF-κB activation, reduced net insulin-stimulated glucose uptake by 30%,
GLUT4 translocation by 35%, Akt phosphorylation by 31%, and a 0.7-fold increase in insulin-stimulated
insulin receptor substrate 1 (IRS-1) phosphorylation [84]. The enhancement of GLUT4 expression via
NF-κB has also been confirmed in other models [85]. Furthermore, other authors have demonstrated in
adipocytes that the IκB kinase β (IKKβ), c-Jun N-terminal kinase (JNK), and S6K and mTOR32 kinases
carry out inhibitory phosphorylation of IRS-1, thus causing insulin resistance [9]. Both experimental
and clinical studies now converge to show that several ILs contribute to the pathology and physiology
of Type 2 diabetes through their interaction with insulin signaling pathways and β-cell functions.
Notably, IL-1, which is a major proinflammatory cytokine, is present at increased levels in patients with
diabetes mellitus, and could promote β-cell destruction and alter insulin sensitivity [86]. Likewise,
IL-6 has been suggested to be involved in the development of obesity-related and diabetes mellitus
Type 2-related insulin resistance. The action of IL-6 on glucose homeostasis is also complex, and
integrates central and peripheral mechanisms [87]. Overall, these data demonstrate that acidosis has
the potential to indirectly cause insulin resistance via the activation of NF-κB pathways and the release
of inflammatory cytokines, an already well-known cause of chronic inflammation in diabetic patients.
7. Conclusions
Acidosis modulates insulin sensitivity and resistance in many different and complex ways.
Notably, the timing of exposure to acidosis is a crucial factor in this context, since acute and chronic
effects of acidosis may have completely opposite effects. To control acid-related diseases, several
approaches have been suggested in mouse models, including the use of bicarbonate [4,88]. Once
translated to the clinical practice, however, results obtained from these studies might produce quite
uncertain and dangerous effects in humans. For diseases associated with insulin resistance, like for
type 2 diabetes, decreasing dietary acid load may be an achievable alternative and a relevant route
to improve glucose homeostasis and prevention on a long-term basis. However, limitations related
to patient acid load estimation, nutritional determinants, and metabolic status considerably flaws
available findings, and the lack of solid data on the background pathophysiology contributes to the
questionability of results. Furthermore, evidence from interventional studies is very limited and the
trials carried out so far report no beneficial results following alkali supplementation [89]. Nevertheless,
the relation between insulin metabolism and the regulation of pH is an exciting and fascinating field of
investigation for the identification of novel therapeutic approaches. Furthermore, in clinical practice,
data that have been collected so far suggest considering pH not only as a body parameter to be
continuously kept under control to avoid the dangerous effects of systemic acidosis or alkalosis, but
also as a main driver that directly modulates crucial biological processes, either at the systemic, cellular,
or molecular level.
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